Research map: Efficacy and safety of hepatic arterial infusion chemotherapy plus lenvatinib and PD-1/PD-L1 inhibitors versus systemic chemotherapy plus lenvatinib and PD-1/PD-L1 inhibitors in advanced unresectable cholangiocarcinoma: a retrospective cohort study

Back to the article

Papers in this map

  1. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1) · E. A. Eisenhauer · 2008 · 30146 citations · Cited by this paper
  2. CEACAM6 silencing suppresses tumour growth and sensitises cholangiocarcinoma to cisplatin · Shi‐jia Dai · 2026 · 1 citation · Cites this paper
  3. HBO1 suppresses anti-tumor immunity of CD8⁺ T Cells in thyroid cancer by recruiting BRD4 to regulate VTCN1 expression · 2026 · Related
  4. Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial · Robin Kate Kelley · 2023 · 1156 citations · Cited by this paper
  5. First-Line Hepatic Arterial Infusion Chemotherapy Plus Immune Checkpoint Inhibitors Versus Systemic Chemotherapy Plus Immune Checkpoint Inhibitors for Unresectable Intrahepatic Cholangiocarcinoma · Wenyi Zhang · 2026 · Cites this paper
  6. Conserved minimal CD8 cytotoxic immune-state unit in an IL18R1-associated immune program in hepatocellular carcinoma · 2026 · Related
  7. Cholangiocarcinoma — novel biological insights and therapeutic strategies · Sumera Irie Ilyas · 2023 · 219 citations · Cited by this paper
  8. Impact of neck nodal yield on immune checkpoint inhibitor outcome after recurrence in head and neck squamous cell carcinoma · 2026 · Related
  9. Untitled · Cited by this paper
  10. Preclinical efficacy of iPSC-derived MUC1-targeted CAR-NK cells against esophageal squamous cell carcinoma · 2026 · Related
  11. Untitled · Cited by this paper
  12. Survival outcomes of conversion curative therapy following atezolizumab–bevacizumab in advanced hepatocellular carcinoma · 2026 · Related
  13. Untitled · Cited by this paper
  14. Integrative single-cell and multi-omics analysis of ZBTB21-mediated serine metabolism in colorectal cancer: from metabolic reprogramming to immune microenvironment modulation · 2026 · Related
  15. Untitled · Cited by this paper
  16. Squeezing Treatment-Induced Metabolic Alterations in Melanoma Cells Are Accompanied by Impaired Cluster of Differentiation 8-Positive T Cell and Natural Killer Cell Antitumor Effector Functions · 2026 · Related
  17. Untitled · Cited by this paper
  18. Efficacy and safety of anti-PD-1 combined with IFN-α1b with or without anlotinib as the first-line therapy in patients with unresectable advanced melanoma: a real-world cohort study · 2026 · Related
  19. Untitled · Cited by this paper
  20. Spatially fractionated radiotherapy with PD-L1 blockade achieves superior antitumor efficacy and safety in a preclinical model of peritoneal metastasis · 2026 · Related
  21. Untitled · Cited by this paper
  22. Untitled · Cited by this paper
  23. Untitled · Cited by this paper
  24. Untitled · Cited by this paper
  25. Untitled · Cited by this paper
  26. Untitled · Cited by this paper
  27. Untitled · Cited by this paper
  28. Untitled · Cited by this paper
  29. Untitled · Cited by this paper
  30. Untitled · Cited by this paper
  31. Untitled · Cited by this paper
  32. Untitled · Cited by this paper
  33. Untitled · Cited by this paper
  34. Untitled · Cited by this paper
  35. Untitled · Cited by this paper
  36. Untitled · Cited by this paper
  37. Untitled · Cited by this paper

Source: OpenAlex (CC0)